Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ·Healthcare·Biotechnology
$14.96
-1.74%
Mkt Cap $1.96B
Analyst Ratings
No recent rating data.
Price Target (9 analysts)
$12.60
Range $6.00 – $16.00
Implied Upside
-15.8%
Consensus $12.60 vs current $14.96
NASDAQ·Healthcare·Biotechnology
$14.96
-1.74%
Mkt Cap $1.96B
No recent rating data.
Price Target (9 analysts)
$12.60
Range $6.00 – $16.00
-15.8%
Consensus $12.60 vs current $14.96